Previous Article | Next Article ![]()
Journal of Virology, July 1999, p. 5663-5670, Vol. 73, No. 7
Hybridon, Cambridge, Massachusetts
02139,1 and Department of Biological
Chemistry and Molecular Pharmacology, Harvard Medical School,
Boston, Massachusetts 021152
Received 30 November 1998/Accepted 24 March 1999
Human cytomegalovirus encodes a protein kinase (UL97) that confers
sensitivity to ganciclovir by phosphorylating it to the monophosphate.
The function of this unusual kinase in viral replication is unknown. We
constructed two independent isolates of a recombinant virus, RC
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
A Recombinant Human Cytomegalovirus with a Large
Deletion in UL97 Has a Severe Replication
Deficiency

and
97,
that contain large deletions in this gene and carry a 4.8-kb insertion
containing a selectable genetic marker. These mutant viruses were
isolated by using a population of primary cells (HEL97) that express
this gene from integrated copies of a defective retroviral vector. The
recombinant viruses were severely impaired in their ability to
replicate in primary fibroblasts, attaining virus titers that were 2 to
3 orders of magnitude lower than those produced by the parent virus.
Despite the severe replication deficit, both of these viruses retained
the ability to form small, slowly growing plaques in primary
fibroblasts, demonstrating that UL97 is not absolutely essential for
replication in cell culture. The replication deficit was relieved when
UL97 was provided in trans in the complementing cell line,
showing that the phenotype was due to a deficiency in UL97. Thus, the
UL97 gene product plays a very important role in viral
replication in tissue culture and may be a good target for antiviral chemotherapy.
*
Corresponding author. Present address: Iconix
Pharmaceuticals Inc., 850 Maude Ave., Mountain View, CA 94043. Phone:
(650) 567-5515. Fax: (650) 526-3034. E-mail:
mprichard{at}iconixpharm.com.
Present address: Astra Research Center Boston, Cambridge, MA 02139.
Present address: Schleicher & Schuell, Inc., Keene, NH 03431.
§
Present address: Department of Microbiology and Nevada State Health
Laboratory, School of Medicine, University of Nevada, Reno, NV 89557.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|